COMMUNIcation and Patient Engagement at Diagnosis of PAncreatic CAncer

The diagnosis of PDAC in most cases is completely unforeseen for the patient, who faces with the disease already at an advanced stage and without a progressive approach to it. The clinical interview in which the diagnosis and the first information regarding treatment options and prognosis are communicated assumes a strong relevance, since it is an unexpected diagnosis with a poor prognosis.

Doctor-patient communication is an integral part of the care itself and poses the basis for the construction of the therapeutic alliance, an essential condition for compliance of the patient with reference to the treatments proposed by the physician.

Many recent studies claim that a good level of patient engagement is an essential condition for building a solid therapeutic alliance; in this regard, objective measurement scales of the patient engagement level have been developed, and have been demonstrated to be useful for quantifying the patient's involvement within the care process Among them is the Patient Health Engagement Scale (PHE-S®)-Scale, a recently validated assessment scale of simple and non-invasive use, that requires only the administration of a questionnaire to the previously informed patient who gives his consent.

The hypothesis of this study is that the clarity of the communication between the treating physician and the patient, and the level of understanding by the patient of the information conveyed by the doctor, in particular at the time of diagnosis largely influences the construction of a solid therapeutic alliance between the treating physician and PDAC patients and consequently the patient's engagement and compliance in the care process.

Our hypothesis is that the clarity of the communication between the treating physician and the patient and the degree of comprehension by the patient, especially during the first phases of the cure, are associated with the level of engagement and consequently with the compliance of patients with PDAC.

If the present pilot study will support the initial hypothesis, further action to improve the clarity of the clinical communication will be promoted.

Inclusion criteria

• Adult patients (≥18 years);
• Of Italian mother tongue;
• Have a histologic diagnosis of PDAC obtained during the 4 weeks before the visit
• The visit is the first visit after completion of diagnostic procedures and is set to communicate the diagnosis and treatment strategies
• Give full, written informed consent

Exclusion criteria

• PDAC recurrence after previous diagnosis and treatment
• Poor performance status (ECOG ≥ 3